Shenzhen - Delayed Quote • HKD
China National Accord Medicines Corporation Ltd. (200028.SZ)
As of 12:13 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
75,477,484.62
75,477,484.62
73,443,136.99
68,357,809.57
59,649,455.01
Cost of Revenue
66,425,425.56
66,425,425.56
64,516,926.01
60,339,298.05
52,591,767.46
Gross Profit
9,052,059.06
9,052,059.06
8,926,210.98
8,018,511.52
7,057,687.55
Operating Expense
6,552,699.07
6,552,699.07
6,513,741.20
5,864,548.07
5,033,580.55
Operating Income
2,499,359.99
2,499,359.99
2,412,469.78
2,153,963.45
2,024,107.00
Net Non Operating Interest Income Expense
-207,489.33
-207,489.33
-189,077.21
-212,897.31
-119,802.63
Pretax Income
2,473,226.54
2,473,226.54
2,311,070.12
1,974,852.85
2,157,236.45
Tax Provision
514,739.44
514,739.44
539,332.13
447,210.65
435,940.05
Net Income Common Stockholders
1,599,255.76
1,599,255.76
1,486,707.65
1,336,427.75
1,401,892.59
Basic EPS
2.87
--
2.67
2.40
2.52
Diluted EPS
2.87
--
2.67
2.40
2.52
Basic Average Shares
557,231.97
--
556,819.35
556,844.90
557,327.33
Diluted Average Shares
557,231.97
--
556,819.35
556,844.90
557,327.33
Total Operating Income as Reported
2,467,425.16
2,467,425.16
2,306,068.62
1,952,411.26
2,163,841.14
Rent Expense Supplemental
20,008.62
20,008.62
24,785.35
31,250.66
26,955.39
Total Expenses
72,978,124.63
72,978,124.63
71,030,667.21
66,203,846.12
57,625,348.01
Net Income from Continuing & Discontinued Operation
1,599,255.76
1,599,255.76
1,486,707.65
1,336,427.75
1,401,892.59
Normalized Income
1,688,378.71
1,688,378.71
1,673,984.61
1,590,811.85
1,482,087.66
Interest Income
77,554.16
77,554.16
72,935.65
74,297.77
136,455.99
Interest Expense
248,381.40
248,381.40
261,908.26
288,038.76
258,189.16
Net Interest Income
-207,489.33
-207,489.33
-189,077.21
-212,897.31
-119,802.63
EBIT
2,721,607.95
2,721,607.95
2,572,978.38
2,262,891.61
2,415,425.61
EBITDA
4,147,262.72
4,147,262.72
3,880,404.22
3,531,072.25
3,473,332.53
Reconciled Cost of Revenue
66,425,425.56
66,425,425.56
64,516,926.01
60,339,298.05
52,591,767.46
Reconciled Depreciation
1,425,654.77
1,425,654.77
1,307,425.84
1,268,180.64
1,057,906.91
Net Income from Continuing Operation Net Minority Interest
1,599,255.76
1,599,255.76
1,486,707.65
1,336,427.75
1,401,892.59
Total Unusual Items Excluding Goodwill
-112,546.69
-112,546.69
-244,285.65
-328,853.94
-100,505.48
Total Unusual Items
-112,546.69
-112,546.69
-244,285.65
-328,853.94
-100,505.48
Normalized EBITDA
4,259,809.41
4,259,809.41
4,124,689.87
3,859,926.19
3,573,838.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-23,423.74
-23,423.74
-57,008.70
-74,469.84
-20,310.41
12/31/2020 - 8/10/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade